Glioma
|
0.700 |
Biomarker
|
disease |
CTD_human |
We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)).
|
19578367 |
2009 |
Glioma
|
0.700 |
Biomarker
|
disease |
CTD_human |
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
|
19578366 |
2009 |
Glioma
|
0.700 |
CausalMutation
|
disease |
CGI |
|
|
|
Glioma
|
0.700 |
GenomicAlterations
|
disease |
CGI |
|
|
|
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
CTD_human |
In 3 of the 14 regions, TCF7L2 (T2D), CTLA4 (Graves' disease) and CDKN2A-CDKN2B (T2D), much of the posterior probability rested on a single SNP, and, in 4 other regions (CDKN2A-CDKN2B (CAD) and CDKAL1, FTO and HHEX (T2D)), the 95% sets were small, thereby excluding most SNPs as potentially causal.
|
23104008 |
2012 |
Glaucoma
|
0.450 |
Biomarker
|
disease |
CTD_human |
We also show that CDKN2A and CDKN2B are upregulated in the retina of a rat model of glaucoma.
|
21532571 |
2011 |
MYELODYSPLASTIC SYNDROME
|
0.400 |
Biomarker
|
group |
CTD_human |
P15INK4B gene hypermethylation is closely associated with MDS pathogenesis.
|
17294728 |
2007 |
Lymphoma
|
0.400 |
Biomarker
|
group |
CTD_human |
The p15INK4b promoter region was hypermethylated in two additional 2',3'-dideoxycytidine-induced lymphomas.
|
9488045 |
1998 |
Malignant Neoplasms
|
0.400 |
CausalMutation
|
group |
CGI |
|
|
|
Malignant Neoplasms
|
0.400 |
GenomicAlterations
|
group |
CGI |
|
|
|
Coronary Arteriosclerosis
|
0.360 |
Biomarker
|
disease |
CTD_human |
Bayesian refinement of association signals for 14 loci in 3 common diseases.
|
23104008 |
2012 |
Malignant Glioma
|
0.340 |
Biomarker
|
disease |
CTD_human |
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
|
19578366 |
2009 |
Malignant Glioma
|
0.340 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study identifies five susceptibility loci for glioma.
|
19578367 |
2009 |
Adenocarcinoma of lung (disorder)
|
0.330 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Multiple Endocrine Neoplasia Type 1
|
0.310 |
GeneticVariation
|
disease |
ORPHANET |
Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.
|
19141585 |
2009 |
mixed gliomas
|
0.300 |
Biomarker
|
disease |
CTD_human |
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
|
19578366 |
2009 |
mixed gliomas
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study identifies five susceptibility loci for glioma.
|
19578367 |
2009 |
Hematopoetic Myelodysplasia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
[Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
|
17294728 |
2007 |
Familial Atypical Mole Melanoma Syndrome
|
0.300 |
GeneticVariation
|
disease |
ORPHANET |
|
|
|